Archive |
Tags
Reshaping the landscape of cancer drug discovery and development
By Dr Paolo Paoletti
The landscape of cancer drug discovery and development is shifting – adjusting and reshaping itself in response to the huge rush of scientific knowledge more...Human ES Cell Derived Functional Cells as Tools in Drug Discovery
By Dr Petter Björquist, Dr Peter Sartipy, Dr Raimund Strehl and Dr Johan...
The drug discovery process is extremely-time consuming and expensive. Consequently, novel approaches for these processes and for reducing late-stage attrition are of great value for the pharmaceutical industry.
more...
Opportunities in Gastroenterology
By Dirk Reyn
Despite being one of the world’s largest therapeutic areas and presenting huge burdens to healthcare and economies globally, many of the diseases of the gastrointestinal (GI) tract are not well understood and less than optimally treated.
more...
Stem Cell Applications and Opportunities in Drug Discovery
By Dr Mark A. Thiede
The high attrition rate of late stage drug candidates has led the pharmaceutical and biotech industries to a reassess the in vitro models used to select and validate drug targets and subsequent lead molecules.
more...
Is amyloid-related toxicity an inevitable consequence of ageing?
By Dr J Mark Treherne and Dr David IC Scopes
Amyloid-related toxicity need not necessarily be the inevitable consequence of ageing, if some of the new drug discovery strategies to treat neurodegenerative and other ageing-related diseases succeed in the clinic.
more...